In the morning, the total subscribed principal of the structured deposit product of the associated fund of Sunrise Ophthalmology (02219) is 31.8 million US dollars.

Zhixin Finance APP News, Chaoju Ophthalmology (02219) announced that on June 10, 2026, Chaoju Ophthalmology Medical (Hong Kong) Limited (Chaoju Hong Kong) (an indirect wholly-owned subsidiary of the Company) subscribed to a structured deposit product provided by JPMorgan Chase Bank, N.A. (JPMorgan Chase Bank) with a principal amount of 31.8 million US dollars.